Clinical Trial Update: Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating fluorescein as an intraoperative biomarker to improve detection of brain tumors during surgery (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• Fluorescein (fluorescein sodium)

Snippet

Sponsor: David W. Roberts | Conditions: Brain Cancer | Phase 2 | Status: RECRUITING